JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India TFCI MD Discusses Business Outlook Jim Cramers Ongoing Investigation of Adobe Sparks Market Interest Dropboxs RemoteFirst Strategy Strengthens Recruitment and Financial Performance Amid ReturntoOffice Trend Czech Police Orders 11 Airbus H145 Helicopters in Fleet Modernization Deal OpenAI Emerges as Frontrunner in AI IPO Race as Confidential Filing Approaches Iran Tariffs on Hormuz Internet Cables May Raise Europes Connectivity Costs QCLS Q4 2017 Earnings Massive EPS Miss with Negative Earnings Despite Stock Rise IVVD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress Natuzzi SpA NTZ Q4 2011 Earnings EPS Falls Short as Restructuring Weighs on Results STRC Q1 2026 Earnings Massive EPS Miss Highlights Challenges for Preferred Stock Currenc Group Inc CURR Q3 2025 Earnings EPS Surges Past Estimates Yet Shares Slide BETR Q1 2026 Earnings WiderthanExpected Loss as Company Navigates Challenging Market Apollomics Warrants APLMW Hold at 001 After Modest Gain Tight Trading Range Persists HeartSciences Inc HSCS Declines Over 7 as Stock Tests Key Support Near 170 Mobix Labs MOBX Rebounds Testing Key Resistance at 229 Amidst Sector Rotation CN Energy Group CNEY Drops 545 Testing Critical Support at 181 KTWOU Holds Steady at 1011 K2 Capital Acquisition Units Trade Flat Amid SPAC Market Caution BRP Inc DOO Gains Ground as Shares Approach Key Resistance Level UDR Inc Gains 133 as Apartment REIT Benefits from Sector Rotation Titan Machinery TITN Consolidates Near Support as Agricultural Sector Uncertainty Persists DFP Edges Higher Preferred Income Fund Shows Resilient Price Action Amid Sector Shifts Fermi Inc FRMI Surges 419 as Bulls Test Key Resistance at 72 Lithia Motors LAD Edges Higher Navigating Key Support and Resistance Levels Mortgage Rates Remain Stubbornly High Despite Fed Rate Cut Whats Behind the Divergence STTK Q1 2026 Earnings Narrower Loss Surprises No Revenue as Pipeline Progress Continues Palvella Therapeutics PVLA Slips 166 as Shares Test Key Support Levels